Clinical experience in rehabilitation of patients with Fuchs corneal dystrophy and cataract by ultrasonic phacoemulsification and descemetorhexis
- Authors: Katmakov K.I.1, Pashtaev A.N.1, Pashtaev N.P.1, Elakov Y.N.1, Mitrofanova Y.V.2, Pozdeyeva N.A.1, Gelyastanov A.M.3
-
Affiliations:
- S. Fyodorov Eye Microsurgery Federal State Institution, Cheboksary branch
- Postgraduate Doctors Training Institute
- S. Fyodorov Eye Microsurgery Federal State Institution, Kaluga branch
- Issue: Vol 16, No 3 (2023)
- Pages: 89-97
- Section: Case reports
- URL: https://journals.rcsi.science/ov/article/view/148224
- DOI: https://doi.org/10.17816/OV375368
- ID: 148224
Cite item
Abstract
BACKGROUND: The potential for peripheral corneal endothelial capabilities is a novel, poorly understood direction. The comprehensive development of various modifications of endothelial keratoplasty goes hand in hand with a lack of donor material. This explains the continuous search for safe tissue-preserving techniques.
AIM: The aim of this study is to evaluate the clinical and functional results of treatment of patients with Fuchs corneal dystrophy and cataract using a combination of cataract ultrasound phacoemulsification and descemetorhexis.
MATERIALS AND METHODS: The study included 3 patients (3 eyes), 3 women aged 65 to 78 (on average 73.6 ± 7.5 years). The follow-up period in the postoperative period was 36 months. The inclusion criteria were: patient complaints about glare, blurred vision and cloudy vision in the morning; the location of the guttae in the central 5 mm zone, central corneal stromal edema less than 610 microns, the inability to count endothelial cells in the center, endothelial cells density on the periphery in the upper quadrant more than 1400 cells/mm2. All patients underwent phacoemulsification of cataract with IOL implantation and subsequent descemetorhexis in the 4 mm zone.
RESULTS: At 1 month — an increase in the central corneal thickness and a slight increase in uncorrected visual acuity (UCVA) and in best corrected visual acuity (BCVA). By the 3rd month, positive dynamics was present: an increase in UCVA and BCVA in all cases, a decrease in the central corneal thickness (559 ± 20 μm), resorption of stromal edema, increase in corneal transparency, possibility to calculate the endothelial cells density in the center (866 ± 46 cells/mm2). At 36 months, the BCVA was 0.6, 0.4 and 0.5, respectively.
CONCLUSIONS: Restoration of corneal transparency was achieved in 100% of cases (3 out of 3). An analysis of the clinical results of the descemetorhexis + phacoemulsification + IOL operation demonstrated an increase in visual acuity, an increase in corneal transparency and a decrease in stromal edema in patients with initial Fuchs corneal dystrophy and cataract. The possibility of not using donor material for the treatment of Fuchs corneal dystrophy is a promising trend. Further accumulation of material is required.
Full Text
##article.viewOnOriginalSite##About the authors
Konstantin I. Katmakov
S. Fyodorov Eye Microsurgery Federal State Institution, Cheboksary branch
Author for correspondence.
Email: katmakovkostya@yandex.ru
ORCID iD: 0000-0001-5521-3781
SPIN-code: 3650-0973
Scopus Author ID: 57217072651
ResearcherId: AAI-4226-2020
MD, Cand. Sci. (Med.) Ophthalmologist
Russian Federation, CheboksaryAleksei N. Pashtaev
S. Fyodorov Eye Microsurgery Federal State Institution, Cheboksary branch
Email: PashtaevMD@gmail.com
ORCID iD: 0000-0003-2305-1401
Scopus Author ID: 57205260939
MD, Dr. Sci. (Med.), Senior Research Associate
Russian Federation, CheboksaryNikolai P. Pashtaev
S. Fyodorov Eye Microsurgery Federal State Institution, Cheboksary branch
Email: pashtaevnp@gmail.com
ORCID iD: 0000-0001-7941-2996
Scopus Author ID: 6507569608
MD, Dr. Sci. (Med.), Professor, Deputy Director, Ophthalmologist
Russian Federation, CheboksaryYurii N. Elakov
S. Fyodorov Eye Microsurgery Federal State Institution, Cheboksary branch
Email: elakovmntk@gmail.com
ORCID iD: 0000-0001-6751-3255
Head of the Cataract Surgery Department, Ophthalmologist
Russian Federation, CheboksaryYulia V. Mitrofanova
Postgraduate Doctors Training Institute
Email: mitrofan2697@gmail.com
ORCID iD: 0000-0002-5360-5375
Resident Doctor
Russian Federation, CheboksaryNadezhda A. Pozdeyeva
S. Fyodorov Eye Microsurgery Federal State Institution, Cheboksary branch
Email: npozdeeva@mail.ru
ORCID iD: 0000-0003-3637-3645
Scopus Author ID: 57195066807
MD, Dr. Sci. (Med.), director of Cheboksary branch
Russian Federation, CheboksaryAslan M. Gelyastanov
S. Fyodorov Eye Microsurgery Federal State Institution, Kaluga branch
Email: aslan.mntk@gmail.com
ORCID iD: 0000-0003-4011-8831
Scopus Author ID: 57200246416
MD, Cand. Sci. (Med.), Ophthalmologist
Russian Federation, KalugaReferences
- Cross HE, Maumenee AE, Cantolino SJ. Inheritance of Fuchs’ endothelial dystrophy. Arch Ophthalmol. 1971;85(3):268–272. doi: 10.1001/archopht.1971.00990050270002
- Krachmer JH, Purcell JJ, Young CW et al. Corneal endothelial dystrophy. Arch Ophthalmol. 1978;96(11):2036–2039. doi: 10.1001/archopht.1978.03910060424004
- Astakhov SYu, Riks IA, Papanyan SS, et al. Comparative assessment of the efficacy of primary and secondary corneal endothelial dystrophy treatment by isolated descemetorhexis and accelerated collagen crosslinking method. Ophthalmology Reports. 2018;11(2):41–47. (In Russ.) doi: 10.17816/OV11241-47
- Laing RA, Leibowitz HM, Oak SS, et al. Endothelial mosaic in Fuchs’ dystrophy. A qualitative evaluation with the specular microscope. Arch Ophthalmol. 1981;99(1):80–83. doi: 10.1001/archopht.1981.03930010082007
- Iwamoto T, DeVoe AG. Electron microscopic studies on Fuchs combined dystrophy I. Posterior portion of the cornea. Invest Ophthalmol. 1971;10(1):9–28.
- Waring GO. Posterior collagenus layer of the cornea. Ultrastructural classification of abnormal collagenus tissue posterior to Descemet’s membrane in 30 cases. Arch Ophthalmol. 1982;100(1): 122–134. doi: 10.1001/archopht.1982.01030030124015
- Gardea E, Adam P, Brasseur G, Muraine M. Descemet membrane graft in a patient with Fuchs endothelial dystroph. J Fr Ophtalmol. 2007;30(6):658–659. doi: 10.1016/s0181-5512(07)89675-6
- Koizumi N, Okumura N, Kinoshita S. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Exp Eye Res. 2012;95(1):60–67. doi: 10.1016/j.exer.2011.10.014
- Rizwan M, Peh GS, Adnan K, et al. In vitro topographical model of Fuchs dystrophy for evaluation of corneal endothelial cell monolayer formation. Adv Healthc Mater. 2016;5(22):2896–2910. doi: 10.1002/adhm.201600848
- Droutsas K, Lazaridis A, Koutsandrea C, et al. Spontaneous corneal clearance in the presence of a partially detached graft after non-Descemet stripping automated endothelial keratoplasty. Case Rep Ophthalmol. 2016;7(2):321–327. doi: 10.1159/000443632
- Dirisamer M, Ham L, Dapena I, et al. Descemet membrane endothelial transfer: «free-floating» donor Descemet implantation as a potential alternative to «keratoplasty». Cornea. 2012;31(2):194–197. doi: 10.1097/ICO.0b013e31821c9afc
- Moloney G, Chan UT, Hamilton A, et al. Descemetorhexis for Fuchs’ dystrophy. Can J Ophthalmol. 2015;50(1):68–72. doi: 10.1016/j.jcjo.2014.10.014
- Malyugin BE, Izmaylova SB, Malyutina EA, et al. Clinical and functional results of one-step phaco surgery and central descemetorhexis for cataract and fuchs primary endothelial corneal dystrophy. Vestnik Oftalmologii. 2017;133(6):16–22. (In Russ.) doi: 10.17116/oftalma2017133616-22
- Moloney G, Petsoglou C, Ball M. Descemetorhexis without grafting for fuchs endothelial dystrophy-supplementation with topical ripasudil. Cornea. 2017;36(6):642–648. doi: 10.1097/ICO.0000000000001209
- Macsai MS, Shiloach Mira. Use of topical rho kinase inhibitors in the treatment of Fuchs dystrophy after descemet stripping only. Cornea. 2019;38(5):529–534. doi: 10.1097/ICO.0000000000001883
- Davies E, Ula J, Pineda R. Predictive factors for corneal clearance after descemetorhexis without endothelial keratoplasty. Cornea. 2017;37(2):137–140. doi: 10.1097/ICO.0000000000001427
- Malyugin BE, Malyutina EA, Borzenok SA. Study of human cornea endothelial cells migration into iatrogenic defect zone in experiment ex vivo. Practical Medicine. 2018;16(5):151–157. (In Russ.)
- Koizumi N, Okumura N, Ueno M, et al. New therapeutic modality for corneal endothelial disease using rho-associated kinase inhibitor eye drops. Cornea. 2014;33(Suppl 11): S25–S31. doi: 10.1097/ico.0000000000000240
- Borkar DS, Veldman P, Colby KA. Treatment of Fuchs endothelial dystrophy by descemet stripping without endothelial keratoplasty. Cornea. 2016;35(10):1267–1273. doi: 10.1097/ico.0000000000000915
- Braunstein RE, Airiani S, Chang MA, Odrich MG. Corneal edema resolution after “descemetorhexis”. J Cataract Refract Surg. 2003;29(7):1436–1439. doi: 10.1016/S0886-3350(02)01984-3
- Zvi T, Nadav B, Itamar K, Tova L. Inadvertent descemetorhexis. J Cataract Refract Surg. 2005;31(1):234–235. doi: 10.1016/j.jcrs.2004.11.001
- Patel DV, Phang KL, Grupcheva CN, et al. Surgical detachment of Descemet’s membrane and endothelium imaged over time by in vivo confocal microscopy. Clin Exp Ophthalmol. 2004;32(5): 539–542. doi: 10.1111/j.1442-9071.2004.00875.x